Compare Mongodb Inc (MDB) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mongodb Inc vs Sana Biotechnology Inc — how do they compare? Mongodb Inc trades at $438.21 (market cap $35.32B), while Sana Biotechnology Inc trades at $3.77 (market cap $1.13B). The key difference: Mongodb Inc is far larger — about 31.3× Sana Biotechnology Inc's market cap, and Mongodb Inc is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| MDB | SANA | |
|---|---|---|
Market Cap | $35.32B | $1.13B |
Sector | Technology | Health |
52-Week High | $440.25 | $5.92 |
52-Week Low | $204.37 | $2.68 |
Enterprise Value | $32.93B | $1.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MongoDB (MDB) trades at $439.54, up 5.49% on the day. The stock exhibits a bullish technical trend, with moving averages and overall signals supporting a buy stance, though oscillators show mixed signals. Fundamentally, revenue growth is strong, reaching $2.01B in 2025, but the company remains unprofitable with a net income margin of -1.12%. Recent earnings have consistently beaten expectations, and analyst sentiment is overwhelmingly positive with 81.81% buy ratings.
The outlook for MDB is optimistic due to robust revenue growth and AI-driven demand, but risks include persistent losses and high valuation multiples. The consensus price target of $404.30 suggests potential downside from current levels, indicating caution despite bullish sentiment. Investors should weigh growth prospects against profitability challenges and market volatility.
SANA Biotechnology trades at $3.77, up 4.43% today, with a bullish technical signal from moving averages and ADX indicators. The company reported a net loss of $244.17 million for 2025, with negative cash flow from operations, but analyst consensus is strongly positive with 82% buy ratings. Recent news highlights clinical data presentations and a $9.50 average price target from brokerages as of July 30, 2026.
The outlook hinges on clinical progress driving future profitability, but high cash burn and negative ROE pose significant risks. Upside potential exists if pipeline milestones are met, supported by institutional optimism, though investors face volatility from earnings misses and funding needs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mongodb Inc
Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
Read more on MDB →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
